Last updated 2026-07-26
- Raised $910k Undisclosed Round led by PipelBiz, Aug 2021
- Raised grant, Dec 1969
Total raised
$910K
Last: Undisclosed Round 2021-09
Stage
Seed
Founded
2014
Headcount
1
HQ
Rosh Pinna, Israel
Sector
Health Tech & Life Sciences
About
Algamed Therapeutics specializes in developing technologies dedicated to treating common vaginal conditions, such as dryness, vaginal infections (including yeast infections), menstrual cramps, dyspareunia, and hopefully endometriosis.
The company's first product is Secret de Joie, a natural, hormone-free jelly for treating vaginal dryness. Secret de Joie is intended for breast and ovarian cancer survivors who must avoid taking hormones and women who are postmenopausal, breastfeeding, diabetic, taking birth control pills, and more. The product relieves the dryness that causes discomfort and interferes with intercourse and helps to restore the affected skin.
Funding history · 2 rounds · $910K total
2021-08
Undisclosed Round
$910K
★ PipelBiz
1969-12
Grant
Undisclosed
Headcount over time
From 6 (2021-09) to 1 (2024-01) · -5 (-83%) · 3 points · source: Finder history + radar grounding
Q&A
- What is Algamed Therapeutics' primary focus?
- Algamed Therapeutics specializes in developing technologies for treating common vaginal conditions such as dryness, infections, menstrual cramps, and dyspareunia.
- What is Algamed Therapeutics' first product?
- Algamed Therapeutics' first product is Secret de Joie, a natural, hormone-free jelly designed to treat vaginal dryness.
- Who is the target audience for Secret de Joie?
- Secret de Joie is intended for breast and ovarian cancer survivors who must avoid hormones, as well as postmenopausal, breastfeeding, diabetic, and birth control pill-using women.
- When was Algamed Therapeutics founded?
- Algamed Therapeutics was founded in August 2014.
- How much funding has Algamed Therapeutics raised in total?
- Algamed Therapeutics has raised a total of $910,000.
- When was Algamed Therapeutics' most recent funding round and who participated?
- Algamed Therapeutics' most recent funding round was in September 2021, with participation from PipelBiz.
- What is Algamed Therapeutics' current employee count?
- Algamed Therapeutics has 1-10 employees.
- Who is the CEO of Algamed Therapeutics?
- Efrat Ramati is the CEO of Algamed Therapeutics.
- Does Algamed Therapeutics hold any patents?
- Yes, Algamed Therapeutics holds 1 patent.
Team · 2
CTO & Operations Manager
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMicroorganisms
Target customers
Commerce & RetailDistribution ChannelsDistributorConsumersDemographics & FamilyWomen
Business model
B2CB2B2C
Highlights
1 PatentsVerified
Tags
femtechwomen-healthalgaeanti-inflammatorywomendrug-developmentbiopharmaceuticalpain-relief
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | secretdejoie.co.il/ |
|---|---|
| linkedin.com/company/74034183 | |
| facebook.com/Secretdejoie-104548224758087 | |
| instagram.com/secretdejoie |
Identifiers & details
| Founded | 2014-8 |
|---|---|
| Employees (exact) | 1 |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | secretdejoie.co.il |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515114312 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2014-08-11 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 4 — people (1), charge (3) |
| Registered address | יהלום 20 ראש פינה |
Recent registry events
| Date | Event |
|---|---|
| 2025-11-26 | עדכון בעלי תפקידים |
| 2026-05-26 | רישום שעבוד |
| 2026-04-20 | סילוק שעבוד |
| 2025-12-03 | סילוק שעבוד |